| Common Name | Hu5F9-G4 |
|---|---|
| Synonyms | CD47;MER6;IAP |
| Applications | ELISA; Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000; Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Chimeric Humanized |
| IgG type | IgG4 |
| Reactivity | Human |
| Target | |
| Uniprot ID | Q08722 |
| Description | Anti-CD47 (magrolimab biosimilar, IgG4) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-CD47 (magrolimab biosimilar) mAb
Price: 50 μg ￥800.00 ; 100 μg ￥1500.00
Product Data
图片
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human CD47, mFc-His tagged protein (PME100008) can bind Anti-CD47 (Neutralizing antibody clone Hu5F9-G4) in a linear range of 0.061-1.606 ng/ml.
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD47(A) were surface stained with anti-CD47 neutralizing antibody 1μg/ml (magrolimab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.